View of DRUG REPURPOSING: IDENTIFICATION OF POTENTIAL DRUG TARGETS AGAINST NONSTRUCTURAL PROTEIN 1 (NSP-1) OF SARS-COV-2 THROUGH MOLECULAR DOCKING AND MOLECULAR DYNAMIC SIMULATION USING FDA APPROVED DRUGS

Return to Article Details DRUG REPURPOSING: IDENTIFICATION OF POTENTIAL DRUG TARGETS AGAINST NONSTRUCTURAL PROTEIN 1 (NSP-1) OF SARS-COV-2 THROUGH MOLECULAR DOCKING AND MOLECULAR DYNAMIC SIMULATION USING FDA APPROVED DRUGS Download Download PDF